Biom X Inc. announced it raised $3 Million in an initial filing from an offering of $5 Million
01/04/22, 9:03 PM
Location
Money raised
$3 million
Industry
biotechnology research
Round Type
seed
Company Info
Location
22 einstein st., floor 4
israel
Additional Info
BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.